
Sanofi buys Synthorx Inc for US$2.35bn
Sanofi SA‘s and Synthorx Inc's Boards approved the deal which forsees that Sanofi will acquire all of the outstanding shares of Synthorx for $68 per...

Healx Ltd raises $56m in Series B financing
The financing was led by Atomico and joined by Intel Capital, Global Brain and btov Partners as new investors. Existing investors from a US$10m...

Tecentriq-Avastin combo hits endpoint in liver cancer
Data from 501 treatment-native HCC patients enrolled in the open label IMbrave150 Phase III study demonstrated a incremental improvement...

Patient's organoids predict response to chemotherapy
The organoid-based test, developed by the group of Emile Voest at Netherland’s Cancer Institute in Amsterdam, in a prospective clinical trial...

Update: BIO-Europe growing further
According to still official figures, EBD Group's partnering event in Hamburg, the vibrant centre of Life Science Nord's life science cluster, hit a...

Polyphor presents AMR breaker
In Nature, Anatol Luther et al. from Polyphor AG and the University of Zurich describe the discovery and characterisation of a new class of...

Cellectis presents way to safer CAR-Ts
The company presented the in vitro "proof-of-concept" of their new CAR-T cells, in which they integrated a gene network that senses tumour...